Bellerophon Therapeutics (NSDQ:BLPH) said today that it inked a deal with new and existing investors to raise $23.4 million in a private placement of common stocks and warrants.
The financing was led by Puissance Capital Management and Venrock Healthcare Capital Partners, supported by existing investors like New Mountain Capital and Linde North America, the Warren, N.J.-based company said.
Get the full story at our sister site, Drug Delivery Business News.
The post Bellerophon nabs $23m in private placement appeared first on MassDevice.
from MassDevice http://ift.tt/2y7X0Ls
Cap comentari:
Publica un comentari a l'entrada